{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:42:49Z","timestamp":1773276169125,"version":"3.50.1"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1001\/jamaoncol.2018.4149","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T03:34:28Z","timestamp":1538710468000},"page":"1675","source":"Crossref","is-referenced-by-count":51,"title":["Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses\u2019 Health Studies"],"prefix":"10.1001","volume":"4","author":[{"given":"Mollie E.","family":"Barnard","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Poole","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary C.","family":"Curhan","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Renal Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard A.","family":"Rosner","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"7716","key":"coi180077r2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"issue":"1-2","key":"coi180077r3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","article-title":"Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.","volume":"247","author":"Fleming","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"17","key":"coi180077r4","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer.","volume":"91","author":"Ness","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"coi180077r5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer.","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"issue":"8","key":"coi180077r6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1158\/1055-9965.EPI-16-0120","article-title":"Inflammatory markers of CRP, IL6, TNFa, and soluble TNFR2 and the risk of ovarian cancer: a meta-analysis of prospective studies.","volume":"25","author":"Zeng","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"coi180077r7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1023\/A:1020678100977","article-title":"Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).","volume":"13","author":"Moorman","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"1","key":"coi180077r8","doi-asserted-by":"publisher","first-page":"83e1","DOI":"10.1016\/j.ajog.2006.06.088","article-title":"Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.","volume":"196","author":"Pelucchi","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"coi180077r9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Ovulation and risk of epithelial ovarian cancer.","volume":"104","author":"Purdie","year":"2003","journal-title":"Int J Cancer"},{"issue":"1","key":"coi180077r10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1055-9965.EPI-06-0688","article-title":"Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.","volume":"16","author":"Terry","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"coi180077r11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/aje\/kwt098","article-title":"A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor a receptor 2 levels and risk of ovarian cancer.","volume":"178","author":"Poole","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"2","key":"coi180077r12","doi-asserted-by":"publisher","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.","volume":"106","author":"Trabert","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi180077r13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/annonc\/mdu578","article-title":"Low-dose aspirin use and the risk of ovarian cancer in Denmark.","volume":"26","author":"Baandrup","year":"2015","journal-title":"Ann Oncol"},{"issue":"7","key":"coi180077r14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/bjc.2016.39","article-title":"Analgesic medication use and risk of epithelial ovarian cancer in African American women.","volume":"114","author":"Peres","year":"2016","journal-title":"Br J Cancer"},{"issue":"8","key":"coi180077r15","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/ijc.28823","article-title":"Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women\u2019s Health Initiative.","volume":"135","author":"Brasky","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"coi180077r16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Medication use and risk of ovarian carcinoma: a prospective study.","volume":"108","author":"Lacey","year":"2004","journal-title":"Int J Cancer"},{"issue":"11","key":"coi180077r17","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s10552-012-0063-2","article-title":"Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.","volume":"23","author":"Murphy","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"11","key":"coi180077r18","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1093\/aje\/kwp062","article-title":"Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.","volume":"169","author":"Pinheiro","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"2","key":"coi180077r19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1158\/1055-9965.EPI-09-0976","article-title":"Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women\u2019s Health Study.","volume":"19","author":"Prizment","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"coi180077r20","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1158\/1055-9965.EPI-12-0390-T","article-title":"Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the multiethnic cohort.","volume":"21","author":"Setiawan","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"coi180077r21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","article-title":"Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study.","volume":"88","author":"S\u00f8rensen","year":"2003","journal-title":"Br J Cancer"},{"issue":"3","key":"coi180077r22","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.3802\/jgo.2016.27.e25","article-title":"Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.","volume":"27","author":"Terada","year":"2016","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"coi180077r23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"issue":"1","key":"coi180077r24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/GRF.0b013e3182480523","article-title":"Symptoms associated with ovarian cancer.","volume":"55","author":"Goff","year":"2012","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"coi180077r25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks.","volume":"51","author":"Lunn","year":"1995","journal-title":"Biometrics"},{"issue":"5","key":"coi180077r26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/sim.v35.5","article-title":"Statistical methods for studying disease subtype heterogeneity.","volume":"35","author":"Wang","year":"2016","journal-title":"Stat Med"},{"issue":"2","key":"coi180077r27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"coi180077r28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/j.seminoncol.2015.09.010","article-title":"Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.","volume":"43","author":"Umar","year":"2016","journal-title":"Semin Oncol"},{"issue":"3A","key":"coi180077r29","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs.","volume":"104","author":"Vane","year":"1998","journal-title":"Am J Med"},{"issue":"5-6","key":"coi180077r30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin.","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"issue":"8","key":"coi180077r31","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects.","volume":"45","author":"Capone","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"coi180077r32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc.2016.4","article-title":"Aspirin and colorectal cancer: the promise of precision chemoprevention.","volume":"16","author":"Drew","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"coi180077r33","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/aje\/kwn082","article-title":"Analgesic drug use and risk of epithelial ovarian cancer.","volume":"167","author":"Hannibal","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"6","key":"coi180077r34","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/ijc.v124:6","article-title":"Markers of inflammation and risk of ovarian cancer in Los Angeles County.","volume":"124","author":"Wu","year":"2009","journal-title":"Int J Cancer"},{"issue":"9096","key":"coi180077r35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0140-6736(97)08064-1","article-title":"Over-the-counter analgesics and risk of ovarian cancer.","volume":"351","author":"Cramer","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"coi180077r36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ygyno.2016.04.543","article-title":"Is aspirin use associated with a decreased risk of ovarian cancer? a systematic review and meta-analysis of observational studies with dose-response analysis.","volume":"142","author":"Zhang","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"coi180077r37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/01.HYP.0000177437.07240.70","article-title":"Non-narcotic analgesic dose and risk of incident hypertension in US women.","volume":"46","author":"Forman","year":"2005","journal-title":"Hypertension"},{"issue":"12","key":"coi180077r38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M15-2129","article-title":"Aspirin for the primary prevention of cardiovascular disease and colorectal cancer: a decision analysis for the U.S. Preventive Services Task Force.","volume":"164","author":"Dehmer","year":"2016","journal-title":"Ann Intern Med"},{"key":"coi180077r1","unstructured":"HowladerN, NooneAM, KrapchoM, . SEER Cancer Statistics Review, 1975-2014. https:\/\/seer.cancer.gov\/csr\/1975_2014\/. Published April 2017. Accessed October 3, 2017."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2704211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T11:41:23Z","timestamp":1544701283000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.4149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.4149","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}